PGF and ovarian carcinoma: In this study, other plasma biomarkers including IFNγ, IL-6, IL-8, IL-10, TNFα, placental growth factor (PlGF) were co-assessed with HSP90B1 and adjusted for the well-known cancer antigen CA-125 that is widely expressed in most ovarian cancers [107,108,109].